| The role of the JAK/STAT signal pathway in rheumatoid arthritis |
32 |
| Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria |
20 |
| The clinical potential of romosozumab for the prevention of fractures in postmenopausal women with osteoporosis |
13 |
| New and emerging concepts in the use of denosumab for the treatment of osteoporosis |
12 |
| The role of microbiome in rheumatoid arthritis treatment |
12 |
| New insights and long-term safety of tocilizumab in rheumatoid arthritis |
11 |
| Update on novel pharmacological therapies for osteoarthritis |
11 |
| Recent developments in advanced imaging in gout |
9 |
| Update on the safety and efficacy of teriparatide in the treatment of osteoporosis |
9 |
| Aromatase inhibitors are associated with a higher fracture risk than tamoxifen: a systematic review and meta-analysis |
8 |
| Investigational therapies targeting the granulocyte macrophage colony-stimulating factor receptor-alpha in rheumatoid arthritis: focus on mavrilimumab |
8 |
| Effect of tofacitinib on cardiovascular events and all-cause mortality in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials |
8 |
| New-onset cutaneous sarcoidosis under tocilizumab treatment for giant cell arteritis: a quasi-paradoxical adverse drug reaction. Case report and literature review |
8 |
| Efficacy and safety of sarilumab in patients with active rheumatoid arthritis |
7 |
| Foot osteoarthritis: latest evidence and developments |
6 |
| IL-12/IL-23p40 identified as a downstream target of apremilast in ex vivo models of arthritis |
6 |
| Therapeutic approaches to osteosarcopenia: insights for the clinician |
6 |
| An autumn tale: geriatric rheumatoid arthritis |
5 |
| A narrative review on the difficulties associated with fibromyalgia diagnosis |
5 |
| Inflammation, obesity and rheumatic disease: common mechanistic links. A narrative review |
5 |
| Does periodontitis represent a risk factor for rheumatoid arthritis? A systematic review and meta-analysis |
5 |
| Hidradenitis suppurativa: infection, autoimmunity, or both? |
4 |
| Is there a role for cherries in the management of gout? |
4 |
| The role of secukinumab in the treatment of psoriatic arthritis and ankylosing spondylitis |
4 |
| Musculoskeletal pain and symptoms in pregnancy: a descriptive study |
4 |
| Effectiveness of healthcare educational and behavioral interventions to improve gout outcomes: a systematic review and meta-analysis |
4 |
| The role of epigenetics and immunological imbalance in the etiopathogenesis of psoriasis and psoriatic arthritis |
4 |
| Current advances in the treatment of giant cell arteritis: the role of biologics |
4 |
| Update on the management of hypophosphatasia |
4 |
| Treat-to-target strategy for knee osteoarthritis. International technical expert panel consensus and good clinical practice statements |
3 |
| Health effects of direct triaging to physiotherapists in primary care for patients with musculoskeletal disorders: a pragmatic randomized controlled trial |
3 |
| Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice |
3 |
| Improving drug adherence in osteoporosis: an update on more recent studies |
3 |
| Management of primary Sjogren's syndrome: recent developments and new classification criteria |
3 |
| The effectiveness of Kinesio Taping (R) for pain management in knee osteoarthritis: a randomized, double-blind, controlled clinical trial |
3 |
| Thrombocytosis as a prognostic factor in polymyalgia rheumatica: characteristics determined from cluster analysis |
3 |
| Serum chitotriosidase and neopterin levels in patients with ankylosing spondylitis |
2 |
| Biological therapies and their clinical impact in the treatment of systemic lupus erythematosus |
2 |
| Hypophosphatemia in the setting of metabolic bone disease: case reports and diagnostic algorithm |
1 |
| Mortality risk prediction in lupus patients complicated with invasive infection in the emergency department: LUPHAS score |
1 |
| Indicator opportunistic infections after biological treatment in rheumatoid arthritis, 10 years follow-up in a real-world setting |
1 |
| A randomized, phase IIa study to assess the systemic exposure of triamcinolone acetonide following injection of extended-release triamcinolone acetonide or traditional triamcinolone acetonide into both knees of patients with bilateral knee osteoarthritis |
1 |
| Autologous costal chondral transplantation and costa-derived chondrocyte implantation: emerging surgical techniques |
1 |
| Balancing benefits and risks in the era of biologics |
1 |
| Strengths and weaknesses of the Brazilian regulation on biosimilars: A critical view of the regulatory requirements for biosimilars in Brazil |
0 |
| Helpful, albeit hazardous! Esophageal stem-cell injection in systemic sclerosis |
0 |
| A cross-sectional investigation into the association between Porphyromonas gingivalis and autoantibodies to citrullinated proteins in a German population |
0 |
| The role of golimumab in inflammatory arthritis. A review of the evidence |
0 |
| Assessment of renal function in patients with myositis and treated with subcutaneous immunoglobulin: a series of 24 cases |
0 |
| Functional risk for fracture by safe functional motion testing: a short version of the safe functional motion test |
0 |
